• Kyodo

  • SHARE

Kyoto University’s iPS cell research institute and Takeda Pharmaceutical Co. said Friday they will launch a 10-year, ¥20 billion joint program to focus on regenerative medicine and drug discovery using iPS cells.

Professor Shinya Yamanaka, a Nobel laureate who heads the Center for iPS Cell Research Application, will direct the program while Takeda provides funding and research facilities.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW